BeStock  
Stocks › Biotechnology › SVRA

Savara SVRA

US equityMarket cap rank #3240Biotechnology
$4.88 +$0.23 (+4.95%)
Pre-market · Oct 8, 9:10 am ET · After hours $4.98 +1.95%
Open$4.74
Prev close$4.65
Day range$4.69 – $5.05
Volume2.42M
Market cap$1.00B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$40.97M-30.3% YoY
Net profit-$40.23M-32.3% YoY
Diluted EPS-$0.16-14.3% YoY
Free cash flow-$29.97M-14.1% YoY
Operating cash flow-$29.75M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-24.2MSep '24$-29.0MDec '24$-26.6MMar '25$-30.4MJun '25$-29.6MSep '25$-32.2MDec '25$-37.3MMar '26$-40.2MJun '26

Diluted EPS by quarter

-0.11Sep '24-0.13Dec '24-0.12Mar '25-0.14Jun '25-0.14Sep '25-0.13Dec '25-0.15Mar '26-0.16Jun '26

Free cash flow by quarter

$-22.7MSep '24$-23.3MDec '24$-27.2MMar '25$-26.3MJun '25$-22.5MSep '25$-25.1MDec '25$-33.1MMar '26$-30.0MJun '26

Annual revenue

$257.0KFY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-105.5%
Return on assets-78.3%
Return on invested capital-88.2%
Current ratio10.13
Liabilities / assets25.2%
Cash & investments$173.03M
Total debt$30.11M
Net cash (debt)$142.93M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $40.97M $38.14M $122.76M $33.42M $30.26M
Selling and Admin Expenses $18.99M $15.57M $42.06M $12.53M $9.63M
-General & Admin Expense $18.99M $15.57M $42.06M $12.53M $9.63M
Research & Development $21.95M $23.40M $81.40M $20.90M $20.59M
Depreciation & Amortization & Depletion $28,000.00 $24,000.00 $87,000.00 -$11,000.00 $36,000.00
-Depreciation & Amortization $28,000.00 $24,000.00 $87,000.00 -$11,000.00 $36,000.00
Other Taxes $0.00 -$853,000.00 -$784,000.00 $0.00 $0.00
Operating Profit -$40.97M -$38.14M -$122.76M -$33.42M -$30.26M
Net Non-Operating Interest Income (Expense) $829,000.00 $1.06M $4.16M $1.20M $548,000.00
Non-Operating Interest Income $829,000.00 $1.06M $4.16M $1.20M $548,000.00
Other Income (Expense) -$92,000.00 -$204,000.00 -$236,000.00 -$12,000.00 $146,000.00
Gain on Sale of Security -$92,000.00 -$204,000.00 $310,000.00 -$12,000.00 $146,000.00
Special Income (Charges) $0.00 $0.00 -$546,000.00 $0.00 $0.00
Pretax Profit -$40.23M -$37.28M -$118.84M -$32.24M -$29.56M
Net Profit -$40.23M -$37.28M -$118.84M -$32.24M -$29.56M
Profit from Continuing Operations -$40.23M -$37.28M -$118.84M -$32.24M -$29.56M
Net Income to Parent Company -$40.23M -$37.28M -$118.84M -$32.24M -$29.56M
Net Income to Common Stockholders -$40.23M -$37.28M -$118.84M -$32.24M -$29.56M
Basic EPS -$0.16 -$0.15 -$0.53 -$0.13 -$0.14
Diluted EPS -$0.16 -$0.15 -$0.53 -$0.13 -$0.14
-Less:Other Special Charges – – $546,000.00 $0.00 –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $192.14M $221.65M $253.44M $253.44M $140.92M
Total Current Assets $178.32M $209.27M $241.62M $241.62M $128.20M
Cash and Cash Equivalents & Short-Term Investments $173.03M $202.77M $235.70M $235.70M $124.39M
-Cash and Cash Equivalents $41.80M $38.79M $33.18M $33.18M $16.28M
-Short Term Investments $131.23M $163.98M $202.52M $202.52M $108.11M
Receivables $1.08M $1.05M $1.25M $1.25M $1.10M
-Taxes Receivable $1.08M $1.05M $1.25M $1.25M $1.10M
Prepaid Assets $2.27M $3.82M $3.37M $3.37M $2.18M
Other Current Assets $1.78M $1.37M $892,000.00 $892,000.00 $532,000.00
Total Non-Current Assets $13.82M $12.38M $11.82M $11.82M $12.73M
Net PPE $641,000.00 $130,000.00 $100,000.00 $100,000.00 $85,000.00
Goodwill and Other Intangible Assets $11.29M $11.36M $11.64M $11.64M $11.65M
-Other Intangible Assets $11.29M $11.36M $11.64M $11.64M $11.65M
Other Non-Current Assets $1.89M $886,000.00 $84,000.00 $84,000.00 $990,000.00
Total Liabilities $48.48M $45.61M $50.30M $50.30M $46.54M
Total Current Liabilities $17.60M $15.54M $20.40M $20.40M $16.76M
Payables $7.00M $4.50M $5.76M $5.76M $4.14M
-Accounts Payable $7.00M $4.50M $5.76M $5.76M $4.14M
Current Accrued Expenses $6.20M $9.46M $7.72M $7.72M $8.66M
Short-Term Debt and Capital Lease Obligation $298,000.00 $44,000.00 $7,000.00 $7,000.00 $49,000.00
-Current Capital Lease Obligation $298,000.00 $44,000.00 $7,000.00 $7,000.00 $49,000.00
Other Current Liabilities $385,000.00 $374,000.00 $362,000.00 $362,000.00 –
Total Non-Current Liabilities $30.88M $30.07M $29.91M $29.91M $29.78M
Long Term Debt and Capital Lease Obligation $30.11M $30.07M $29.91M $29.91M $29.78M
-Long Term Debt $30.11M $30.07M $29.91M $29.91M $29.78M
Other Non-Current Liabilities $770,000.00 – – – –
Total Equity $143.66M $176.04M $203.13M $203.13M $94.39M
Stockholders' Equity $143.66M $176.04M $203.13M $203.13M $94.39M
Capital Stock $204,000.00 $204,000.00 $204,000.00 $204,000.00 $173,000.00
-Common Stock $204,000.00 $204,000.00 $204,000.00 $204,000.00 $173,000.00
Additional Paid-In Capital $829.59M $821.64M $811.10M $811.10M $670.22M
Retained Earnings -$685.60M -$645.37M -$608.09M -$608.09M -$575.85M
Gains/Losses Not Affecting Retained Earnings -$534,000.00 -$429,000.00 -$87,000.00 -$87,000.00 -$155,000.00
-Gross PPE – – $2.43M $2.43M –
-Accumulated Depreciation – – -$2.33M -$2.33M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$29.75M -$33.05M -$101.04M -$25.06M -$22.53M
Net cash flow from continuing operations -$29.75M -$33.05M -$101.04M -$25.06M -$22.53M
Net Income from Continuing Operations -$40.23M -$37.28M -$118.84M -$32.24M -$29.56M
Gain/Loss from Continuing Operations $35,000.00 -$12,000.00 $704,000.00 $158,000.00 $0.00
Depreciation & Depletion & Amortization $99,000.00 $66,000.00 $87,000.00 -$129,000.00 $75,000.00
Other Non-Cash Items $43,000.00 $160,000.00 $453,000.00 $126,000.00 $128,000.00
Change in Working Capital $2.96M -$6.14M $5.00M $2.16M $3.83M
-Change in Prepaid Assets $1.48M -$639,000.00 $97,000.00 -$2.35M $712,000.00
-Change in Payables and Accrued Expense $1.48M -$4.64M $4.81M $3.65M $3.12M
-Change in Other Current Assets $0.00 -$864,000.00 $98,000.00 $866,000.00 $0.00
Net cash flow from investing $32.60M $38.78M -$18.44M -$93.56M $21.47M
Net Cash Flow from Continuing Investing Activities $32.60M $38.78M -$18.44M -$93.56M $21.47M
Net PPE Purchase and Sale -$222,000.00 -$54,000.00 -$22,000.00 -$2,000.00 -$2,000.00
Net Investment Purchase and Sale $32.82M $38.83M -$18.42M -$93.56M $21.47M
Financing Cash Flow $189,000.00 -$195,000.00 $137.81M $135.56M -$23,000.00
Net Cash Flow from Continuing Financing Activities $189,000.00 -$195,000.00 $137.81M $135.56M -$23,000.00
Net Issuance Payments Of Debt $0.00 $0.00 $2.37M $0.00 $1,000.00
Net Common Stock Issuance -$5,000.00 -$240,000.00 $135.09M $135.44M -$24,000.00
Proceeds from Stock Option Exercised $194,000.00 $45,000.00 $349,000.00 $119,000.00 $0.00
Ending Cash Balance $41.80M $38.79M $33.18M $33.18M $16.28M
Net Change in Cash $3.04M $5.54M $18.33M $16.94M -$1.09M
Beginning Cash Balance $38.79M $33.18M $15.13M $16.28M $17.44M
Effect of Exchange Rate Changes -$30,000.00 $74,000.00 -$277,000.00 -$36,000.00 -$74,000.00
Free Cash Flow -$29.97M -$33.10M -$101.06M -$25.06M -$22.53M

Discussion

No comments yet — be the first to weigh in on SVRA.

Leave a comment

Scroll to Top